SOX18 and infection: To address the SOX18 role in K-ECFCLYs the cells were treated with siRNA targeting SOX18 or non-targeting control siRNA (siNeg) after five days of infection and analyzed three days later for KSHV genome copies, number of LANA positive cells and infectious virus release on naïve U2OS cells (Fig 4A–4D).